Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: A nationwide retrospective study in Japan

Yutaka Tsukune; Makoto Sasaki; Takeshi Odajima; Kazutaka Sunami; Tomomi Takei; Yukiyoshi Moriuchi; Masaki Iino; Atsushi Isoda; Aya Nakaya; Tsuyoshi Muta; Takaaki Miyake; Koji Miyazaki; Takayuki Shimizu; Kei Nakajima; Aiko Igarashi; Koji Nagafuji; Taro Kurihara; Tomonori Aoyama; Hiroki Sugimori; Norio Komatsu

doi:10.1038/s41408-017-0002-2

Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: A nationwide retrospective study in Japan

Yutaka Tsukune, Makoto Sasaki, Takeshi Odajima, Kazutaka Sunami, Tomomi Takei, Yukiyoshi Moriuchi, Masaki Iino, Atsushi Isoda, Aya Nakaya, Tsuyoshi Muta, Takaaki Miyake, Koji Miyazaki, Takayuki Shimizu, Kei Nakajima, Aiko Igarashi, Koji Nagafuji, Taro Kurihara, Tomonori Aoyama, Hiroki Sugimori, Norio Komatsu

内科学(血液)

研究成果: Letter › 査読

17 被引用数 (Scopus)

本文言語	English
論文番号	631
ジャーナル	Blood cancer journal
巻	7
号	12
DOI	https://doi.org/10.1038/s41408-017-0002-2
出版ステータス	Published - 2017 12月 1

ASJC Scopus subject areas

血液学
腫瘍学

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1038/s41408-017-0002-2

他のファイルとリンク

引用スタイル

Tsukune, Y., Sasaki, M., Odajima, T., Sunami, K., Takei, T., Moriuchi, Y., Iino, M., Isoda, A., Nakaya, A., Muta, T., Miyake, T., Miyazaki, K., Shimizu, T., Nakajima, K., Igarashi, A., Nagafuji, K., Kurihara, T., Aoyama, T., Sugimori, H., & Komatsu, N. (2017). Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: A nationwide retrospective study in Japan. Blood cancer journal, 7(12), 記事 631. https://doi.org/10.1038/s41408-017-0002-2

Tsukune, Y, Sasaki, M, Odajima, T, Sunami, K, Takei, T, Moriuchi, Y, Iino, M, Isoda, A, Nakaya, A, Muta, T, Miyake, T, Miyazaki, K, Shimizu, T, Nakajima, K, Igarashi, A, Nagafuji, K, Kurihara, T, Aoyama, T, Sugimori, H & Komatsu, N 2017, 'Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: A nationwide retrospective study in Japan', Blood cancer journal, vol. 7, no. 12, 631. https://doi.org/10.1038/s41408-017-0002-2

@article{d5db676f7ce54f68b0bbf0774f7b59cf,

title = "Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: A nationwide retrospective study in Japan",

author = "Yutaka Tsukune and Makoto Sasaki and Takeshi Odajima and Kazutaka Sunami and Tomomi Takei and Yukiyoshi Moriuchi and Masaki Iino and Atsushi Isoda and Aya Nakaya and Tsuyoshi Muta and Takaaki Miyake and Koji Miyazaki and Takayuki Shimizu and Kei Nakajima and Aiko Igarashi and Koji Nagafuji and Taro Kurihara and Tomonori Aoyama and Hiroki Sugimori and Norio Komatsu",

note = "Funding Information: We thank all the following physicians of the cooperating hospitals for providing the clinical data: Michiaki Koike (Juntendo University Shizuoka Hospital), Hideto Tamura and Keiichi Moriya (Nippon Medical School), Shigeki Ito and Maki Asahi (Iwate Medical University School of Medicine), Yoichi Imai and Junji Tanaka (Tokyo Women{\textquoteright}s Medical University), Hiroshi Handa and Hiromi Koiso (Gunma University), Sakae Tanosaki (The Fraternity Memorial Hospital), Yoshihiro Hatta (Nihon University School of Medicine), Jian Hua and Masao Hagihara (Eiju General Hospital), Ilseung Choi (National Hospital Organization Kyushu Cancer Center), Naoko Harada (National Hospital Organization Kumamoto Medical Center), Kensuke Ohta (Osaka Saiseikai Nakatsu Hospital), Toshihiro Fukushima (Kanazawa Medical University Hospital), Yoshitaka Imaizumi (Nagasaki University Hospital), Hiroyuki Kuroda (Steel Memorial Muroran Hospital), Yuichi Nakamura (Saitama Medical University Hospital), Tomoharu Takeoka (Otsu Red Cross Hospital), Mitsufumi Nishio (NTT Higashinihon Sapporo Hospital), Takeshi Yamashita (Keiju Kanazawa Hospital), Msayoshi Kobune (Sapporo Medical University School of Medicine), Nobuhiko Nakamura (Gifu University Hospital), Miyuki Ookura (University of Fukui Hospital), Eriko Sato (Juntendo University Nerima Hospital), Masahiro Onozawa (Hokkaido University Graduate School of Medicine), Shikiko Ueno (Kumamoto University Graduate School of Medicine), Riko Tsumanuma (Yamagata Prefectural Central Hospital), Hiroyuki Takamatsu (Kanazawa University Graduate School of Medical Science), Naoko Furuya (Tokyo Medical University), Yoshio Saburi (Oita Prefectural Hospital), Nobuhiko Uoshima (Japanese Red Cross Kyoto Daini Hospital), Tsuyoshi Takahashi (Mitsui Memorial Hospital), Satoru Hasuike (Faculty of Medicine, University of Miyazaki), Tadahiko Igarashi (Gunma Cancer Center), Akio Kohno (JA Aichi Konan Kosei Hospital), Kyoko Inokura (Faculty of Medicine, Yamagata University), Shigeru Hoshino (Saitama Red Cross Hospital), Nobuhito Ohno (Ikeda Hospital), Ayumi Numata (Kanagawa Cancer Center), Atsushi Inagaki (Nagoya City West Medical Center), Tohru Takahashi (Tenshi Hospital), Hirotsugu Kojima (Daido Hospital), Kazuki Tanimoto (Fukuoka Red Cross Hospital), Katsumichi Fujimaki (Fujisawa City Hospital), Yasushi Terasaki (Toyama City Hospital), Hirokazu Okumura (Toyama Prefectural Central Hospital), Tsuyoshi Nakamaki (Showa University School of Medicine), Norisato Hashimoto (Tokai University Hachioji Hospital), Masahide Yamazaki (Keiju Medical Center), Masayuki Ohnishi (Niigata Minami Hospital), Akio Saitoh (Fujioka General Hospital), Tomoyuki Imamura (Oita Memorial Hospital), Hiroto Kaneko (Aiseikai Yamashina Hospital), Masahiro Fujiwara (Kashiwazaki General Hospital and Medical Center), Naoki Harada (Chihaya Hospital), Masato Shikami (Daiyukai General Hospital), Takahiro Karasuno (Rinku General Medical Center), Nobuhisa Hirase (Nakatsu Municipal Hospital), Masanobu Nakata (Seirei Hamamatsu General Hospital), Yoshihito Iwahara (National Hospital Organization Kochi National Hospital), Tatsuyuki Hayashi (Tokyo Metropolitan Police Hospital), Sachiya Takemura (Yokohama Ekisaikai Hospital), Masaru Shibano (Sakai City Medical Center), Naoki Takezako (National Hospital Organization Disaster Medical Center). This work was supported by the grant (Takeda Research Support) from Takeda Pharmaceutical Company (to M.S.).",

year = "2017",

month = dec,

day = "1",

doi = "10.1038/s41408-017-0002-2",

language = "English",

volume = "7",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents

T2 - A nationwide retrospective study in Japan

AU - Tsukune, Yutaka

AU - Sasaki, Makoto

AU - Odajima, Takeshi

AU - Sunami, Kazutaka

AU - Takei, Tomomi

AU - Moriuchi, Yukiyoshi

AU - Iino, Masaki

AU - Isoda, Atsushi

AU - Nakaya, Aya

AU - Muta, Tsuyoshi

AU - Miyake, Takaaki

AU - Miyazaki, Koji

AU - Shimizu, Takayuki

AU - Nakajima, Kei

AU - Igarashi, Aiko

AU - Nagafuji, Koji

AU - Kurihara, Taro

AU - Aoyama, Tomonori

AU - Sugimori, Hiroki

AU - Komatsu, Norio

N1 - Funding Information: We thank all the following physicians of the cooperating hospitals for providing the clinical data: Michiaki Koike (Juntendo University Shizuoka Hospital), Hideto Tamura and Keiichi Moriya (Nippon Medical School), Shigeki Ito and Maki Asahi (Iwate Medical University School of Medicine), Yoichi Imai and Junji Tanaka (Tokyo Women’s Medical University), Hiroshi Handa and Hiromi Koiso (Gunma University), Sakae Tanosaki (The Fraternity Memorial Hospital), Yoshihiro Hatta (Nihon University School of Medicine), Jian Hua and Masao Hagihara (Eiju General Hospital), Ilseung Choi (National Hospital Organization Kyushu Cancer Center), Naoko Harada (National Hospital Organization Kumamoto Medical Center), Kensuke Ohta (Osaka Saiseikai Nakatsu Hospital), Toshihiro Fukushima (Kanazawa Medical University Hospital), Yoshitaka Imaizumi (Nagasaki University Hospital), Hiroyuki Kuroda (Steel Memorial Muroran Hospital), Yuichi Nakamura (Saitama Medical University Hospital), Tomoharu Takeoka (Otsu Red Cross Hospital), Mitsufumi Nishio (NTT Higashinihon Sapporo Hospital), Takeshi Yamashita (Keiju Kanazawa Hospital), Msayoshi Kobune (Sapporo Medical University School of Medicine), Nobuhiko Nakamura (Gifu University Hospital), Miyuki Ookura (University of Fukui Hospital), Eriko Sato (Juntendo University Nerima Hospital), Masahiro Onozawa (Hokkaido University Graduate School of Medicine), Shikiko Ueno (Kumamoto University Graduate School of Medicine), Riko Tsumanuma (Yamagata Prefectural Central Hospital), Hiroyuki Takamatsu (Kanazawa University Graduate School of Medical Science), Naoko Furuya (Tokyo Medical University), Yoshio Saburi (Oita Prefectural Hospital), Nobuhiko Uoshima (Japanese Red Cross Kyoto Daini Hospital), Tsuyoshi Takahashi (Mitsui Memorial Hospital), Satoru Hasuike (Faculty of Medicine, University of Miyazaki), Tadahiko Igarashi (Gunma Cancer Center), Akio Kohno (JA Aichi Konan Kosei Hospital), Kyoko Inokura (Faculty of Medicine, Yamagata University), Shigeru Hoshino (Saitama Red Cross Hospital), Nobuhito Ohno (Ikeda Hospital), Ayumi Numata (Kanagawa Cancer Center), Atsushi Inagaki (Nagoya City West Medical Center), Tohru Takahashi (Tenshi Hospital), Hirotsugu Kojima (Daido Hospital), Kazuki Tanimoto (Fukuoka Red Cross Hospital), Katsumichi Fujimaki (Fujisawa City Hospital), Yasushi Terasaki (Toyama City Hospital), Hirokazu Okumura (Toyama Prefectural Central Hospital), Tsuyoshi Nakamaki (Showa University School of Medicine), Norisato Hashimoto (Tokai University Hachioji Hospital), Masahide Yamazaki (Keiju Medical Center), Masayuki Ohnishi (Niigata Minami Hospital), Akio Saitoh (Fujioka General Hospital), Tomoyuki Imamura (Oita Memorial Hospital), Hiroto Kaneko (Aiseikai Yamashina Hospital), Masahiro Fujiwara (Kashiwazaki General Hospital and Medical Center), Naoki Harada (Chihaya Hospital), Masato Shikami (Daiyukai General Hospital), Takahiro Karasuno (Rinku General Medical Center), Nobuhisa Hirase (Nakatsu Municipal Hospital), Masanobu Nakata (Seirei Hamamatsu General Hospital), Yoshihito Iwahara (National Hospital Organization Kochi National Hospital), Tatsuyuki Hayashi (Tokyo Metropolitan Police Hospital), Sachiya Takemura (Yokohama Ekisaikai Hospital), Masaru Shibano (Sakai City Medical Center), Naoki Takezako (National Hospital Organization Disaster Medical Center). This work was supported by the grant (Takeda Research Support) from Takeda Pharmaceutical Company (to M.S.).

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85034834038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034834038&partnerID=8YFLogxK

U2 - 10.1038/s41408-017-0002-2

DO - 10.1038/s41408-017-0002-2

M3 - Letter

C2 - 29167420

AN - SCOPUS:85034834038

SN - 2044-5385

VL - 7

JO - Blood cancer journal

JF - Blood cancer journal

IS - 12

M1 - 631

ER -